• MHY1485 and the mTORC1 Evidence Gap

  2026-10-09

  MHY1485 is an mTOR activator and autophagy-modulating research tool with applications spanning pathway biology, autophagy assay interpretation, and ovarian follicle development research. This evidence-focused article uses the LMP2A–mTORC1–GCNT3 axis in nasopharyngeal carcinoma to define what MHY1485 can illuminate—and what it cannot establish alone.

• Brain-to-Spinal Control of Mechanical Allodynia

  2026-10-09

  The 2023 Cell Reports study identifies a contralateral lateral parabrachial–hypothalamic–spinal circuit that regulates both the laterality and persistence of mechanical allodynia in mice. Its convergent circuit-mapping and perturbation evidence links lPBN Oprm1 neurons, dmH Pdyn neurons, spinal dynorphin, and kappa-opioid receptor signaling to the opening and closure of bilateral pain-processing gates.

• Human SAN-Plexus Assembloids and Pacemaker Maturation

  2026-10-08

  A 2026 Cell Stem Cell study develops human pluripotent stem cell-derived assembloids that combine sinoatrial node, cardiac ganglionated plexus, and atrial-like tissues to model neuro-cardiac control of pacemaker activity. By integrating electrophysiology with human SAN spatial transcriptomics, the work identifies a prosaposin–GPR37 signaling program associated with pacemaker maturation and provides a human-relevant framework for studying conduction dysfunction.

• Oxaliplatin Resistance: From DNA Damage to Precision

  2026-10-07

  Oxaliplatin is more than a DNA-damaging cytotoxic agent: emerging evidence suggests that its effects on cell-cycle control may expose repair-state vulnerabilities that can be exploited in resistance research. This article interprets a gastric cancer preprint linking compromised CDK1 activity, PARP1, and PARP inhibitor sensitivity while outlining the evidence boundaries, translational questions, and strategic implications for cancer chemotherapy programs.

• 4μ8C in ER Stress and UPR Research

  2026-10-07

  4μ8C, also known as 7-hydroxy-4-methyl-2-oxochromene-8-carbaldehyde, is a small-molecule tool described as a selective inhibitor of IRE1α RNase activity. This overview compares its reported use in hypoxia and cancer research with a 2025 study linking PERK-dependent ER stress to pyroptosis in nucleus pulposus cells, while emphasizing evidence boundaries and the absence of in vivo validation.

• Penicillin G Sodium: Evidence, Scope, and Limits

  2026-10-06

  A source-grounded overview of Penicillin G Sodium, its antibacterial principle, the limits of supplier evidence, and why a recent baicalin methyl ester intestinal-barrier study should not be generalized to penicillin.

• MitMAB and Milk Vesicle Uptake Research

  2026-10-06

  A source-grounded overview of how MitMAB may inform studies of dynamin-linked endocytosis, using recent porcine intestinal stem cell models as context while distinguishing published findings from supplier claims and highlighting important evidence limitations.

• G-Quadruplexes, TDP-43 Condensation, and Toxicity

  2026-10-05

  Oldani et al. show that G-quadruplexes can directly influence TDP-43 aggregation, intracellular distribution, and toxicity across biochemical, yeast, HEK293T, and motor-neuron-like cell models. The study supports RNA structure as a mechanistic regulator of protein condensation, while its ligand findings remain an early-stage basis for neurodegeneration research rather than evidence of a ready therapeutic strategy.

• Midecamycin: Evidence, Mechanism, and Research Context

  2026-10-05

  Midecamycin is a 16-membered macrolide antibiotic investigated for bacterial protein synthesis inhibition, especially in Gram-positive organisms. This overview separates supplier-reported properties from peer-reviewed evidence, examines conceptual microbiology applications, and explains why findings from related spiramycin biosynthesis research cannot be treated as direct evidence for midecamycin.

• Phosphorylation, BMAL1, and Circadian Translation

  2026-10-04

  BMAL1 phase separation reframes phosphorylation as a potential regulator of transcriptional organization, not merely a binary activity switch. This evidence-led perspective explains how Lambda Protein Phosphatase can support phosphorylation-dependent validation while clarifying the limits of broad dephosphorylation for site-specific and translational conclusions.

• Torin2 and the New Logic of Active Cell Death

  2026-10-03

  A translational perspective on Torin2, mTOR pathway biology, and how the 2025 Cell study on RNA Pol II degradation-dependent apoptosis reshapes interpretation of cancer research endpoints.

• MLN8237 (Alisertib) Assay Workflows

  2026-10-01

  Build reproducible Aurora A experiments with MLN8237 (Alisertib), from nanomolar kinase interrogation to apoptosis and mitotic-phenotype profiling. This workflow also shows how the reference study can help distinguish Aurora-linked aneugenic effects from tubulin-driven mechanisms.

• CDK9 inhibitor (A3294): Practical Lab Guide

  2026-10-01

  CDK9 inhibitor (A3294) is a selective serine/threonine kinase inhibitor for probing CDK9-dependent transcription elongation and P-TEFb-related activity. It is suited to biochemical, cell viability, and MT4 HIV-1 propagation inhibition workflows, but it should not be treated as a broad CDK inhibitor or as evidence of clinical efficacy.

• Torin2 Workflows for mTOR-Driven Cancer Research

  2026-09-30

  Torin2 combines nanomolar mTOR inhibition with a practical workflow for pathway validation, viability profiling, and apoptosis assay design. This guide shows how to use it in medullary thyroid carcinoma models while separating mTOR-dependent effects from transcription-linked cell death signals highlighted by a recent preprint.

• Taltirelin, TRHR, and TH in Striatal Neurons

  2026-09-30

  Zhu et al. identify a TRHR–MAPK–RARα–DRD2 signaling axis through which Taltirelin induces tyrosine hydroxylase expression in striatal medium spiny neurons. The study provides a mechanistic explanation for Taltirelin-associated dopaminergic effects in Parkinson’s disease models while emphasizing that TH-positive striatal cells are not necessarily conventional midbrain dopaminergic neurons.

8736 records 1/583 page Next 12345 下5页 Last page